![Charles Wagner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Wagner
Finansdirektör/CFO på
VERTEX PHARMACEUTICALS INCORPORATED
Förmögenhet: 14 M $ per 2026-06-30
Profil
Charles F.
Wagner is currently Chief Executive Officer at ViaCyte, Inc., Independent Director at The TJX Cos., Inc. since 2023, and EVP, Chief Financial & Operating Officer at Vertex Pharmaceuticals, Inc. since 2019.
Former positions include Director at Bruker Energy & Supercon Technologies, Inc. from 2010 to 2013; Director at Good Start Genetics, Inc. from 2014 to 2017; Treasurer & Director at Alpine Immune Sciences, Inc.; Chief Financial Officer & Vice President at EMD Millipore Corp.
from 2002 to 2010; Chief Financial Officer & EVP-Administration at Progress Software Corp.
from 2010 to 2012; Chief Financial Officer & EVP-Administration at Bruker Corp.
from 2012 to 2015; Manager at Bain & Co., Inc. from 1998 to 2002; Manager at Coopers & Lybrand LLP in 1995; Chief Financial Officer & Executive VP-Finance at Ortho-Clinical Diagnostics, Inc. from 2015 to 2019; Chief Financial Officer & Vice President at Merck Life Science AB. Education includes undergraduate studies at Boston College and an MBA from Harvard Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-16 | 27 723 ( 0,01 % ) | 14 M $ | 2026-06-30 | |
| 2026-06-09 | 803 ( 0 % ) | 121 655 $ | 2026-06-30 |
Aktiva positioner av Charles Wagner
| Företag | Position | Start |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Finansdirektör/CFO | 2019-04-10 |
| THE TJX COMPANIES | Direktör/Styrelseledamot | 2023-09-20 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Verkställande Direktör | - |
Tidigare kända positioner av Charles Wagner
| Företag | Position | Slut |
|---|---|---|
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures and designs diagnostic, transfusion, and clinical equipment and systems | Finansdirektör/CFO | 2019-03-01 |
Good Start Genetics, Inc.
 Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Direktör/Styrelseledamot | 2017-08-01 |
| BRUKER CORPORATION | Finansdirektör/CFO | 2015-06-12 |
Bruker Energy & Supercon Technologies, Inc.
 Bruker Energy & Supercon Technologies, Inc. SemiconductorsElectronic Technology Manufactures semiconductor materials & devices | Direktör/Styrelseledamot | 2013-03-01 |
| PROGRESS SOFTWARE CORPORATION | Finansdirektör/CFO | 2012-03-28 |
Charles Wagners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
79
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and production of biotechnology & pharmaceutical drug therapies | Commercial Services |
Progress Software Corp.
 Progress Software Corp. Packaged SoftwareTechnology Services Develops real-time data management software | Technology Services |
The TJX Cos., Inc.
 The TJX Cos., Inc. Apparel/Footwear RetailRetail Trade Retails apparels and home fashion products through offline and online | Retail Trade |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Bruker Energy & Supercon Technologies, Inc.
Bruker Energy & Supercon Technologies, Inc. SemiconductorsElectronic Technology Manufactures semiconductor materials & devices | Electronic Technology |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
Coopers & Lybrand LLP
 Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures and designs diagnostic, transfusion, and clinical equipment and systems | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Life Science AB
 Merck Life Science AB Electronic Equipment/InstrumentsElectronic Technology Provides cutting-edge technologies, tools, and services for bioscience research | Electronic Technology |
Good Start Genetics, Inc.
Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
